The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis Binliang LiuZongbi YiFei Ma Editorial 21 April 2017 Pages: 1 - 11
Ablative Therapies in Metastatic Breast Cancer: A Systematic Review Michael Jonathan KucharczykSameer ParpiaAnand Swaminath Review 11 April 2017 Pages: 13 - 25
Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro Lynn N. ThomasEmily R. ChedraweCatherine K. L. Too Preclinical study 31 March 2017 Pages: 27 - 40
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer Jinil HanYoon-La ChoiYoung Kee Shin Preclinical study Open access 13 April 2017 Pages: 41 - 56
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression Monica E. ReyesTakeo FujiiNaoto T. Ueno Preclinical study 17 April 2017 Pages: 57 - 67
Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients Scott M. MonfortXueliang PanMaryam B. Lustberg Clinical trial 03 April 2017 Pages: 69 - 77
Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema Xiaochen ZhangJustin C. BrownKathryn H. Schmitz Clinical trial 08 April 2017 Pages: 79 - 88
Discerning the clinical relevance of biomarkers in early stage breast cancer Tarah J. BallingerNawal KassemBryan P. Schneider Clinical trial 11 April 2017 Pages: 89 - 97
MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy Mette S. van RamshorstClaudette E. LooGabe S. Sonke Clinical trial 21 April 2017 Pages: 99 - 106
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance) Jeanne S. MandelblattLing CaiArti Hurria Epidemiology 31 March 2017 Pages: 107 - 117
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach Anita AndreanoPaola ReboraAntonio Giampiero Russo Epidemiology 01 April 2017 Pages: 119 - 131
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors Wilfred TruinRudi M. H. RoumenAdri C. Voogd Epidemiology Open access 01 April 2017 Pages: 133 - 138
Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes Scarlett Lin GomezJulie Von BehrenSally L. Glaser Epidemiology 01 April 2017 Pages: 139 - 147
Which women decide to take tamoxifen? Steven A. NarodVictoria SopikPing Sun Epidemiology 03 April 2017 Pages: 149 - 155
Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival Elvira L. VosSabine SieslingLinetta B. Koppert Epidemiology Open access 07 April 2017 Pages: 157 - 167
Sleep quality, duration, and breast cancer aggressiveness Allison SouciseCaila VaughnHeather M. Ochs-Balcom Epidemiology 17 April 2017 Pages: 169 - 178
Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study Noemí CerullaÀngels ArcusaLuís Fernández-Morales Epidemiology 18 April 2017 Pages: 179 - 187
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway Tanda M. DudenkovJames N. IngleRichard M. Weinshilboum Epidemiology 20 April 2017 Pages: 189 - 199
Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival Siddhartha YadavDhiraj YadavDana Zakalik Epidemiology 21 April 2017 Pages: 201 - 208
DNA methylation age is elevated in breast tissue of healthy women Mary E. SehlJill E. HenrySteve Horvath Brief Report Open access 31 March 2017 Pages: 209 - 219
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab Andrew McGuireOlga KalininaMichael J. Kerin Brief Report Open access 04 April 2017 Pages: 221 - 229
Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis Omar Abdel-Rahman Brief Report 17 April 2017 Pages: 231 - 236
Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT) Krishan R. JethwaMohamed M. KahilaRobert W. Mutter Brief Report 17 April 2017 Pages: 237 - 244
Magee equations and oncotype DX®-a perspective Rohit BhargavaDavid J. Dabbs Letter to the Editor 09 April 2017 Pages: 245 - 246
Racial disparity in vitamin D status may explain racial disparity in survival from estrogen and progesterone receptor-positive breast cancer William B. Grant Letter to the Editor 10 April 2017 Pages: 247 - 247
The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated! Bradley TurnerPing TangDavid Hicks Letter to the Editor 13 April 2017 Pages: 249 - 250
Erratum to: Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control M. BourkeD. SodenA. J. P. Clover Erratum 27 May 2017 Pages: 251 - 251
